Virtual Library

Start Your Search

Filter Results:

Show Only Available Presentations

  • +

    FP09 - Novel Therapeutics and Targeted Therapies

    • Type: Posters (Featured)
    • Track: Novel Therapeutics and Targeted Therapies
    • Presentations: 4
    • Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
  • +

    P15 - Immunotherapy (Phase II/III Trials) - Early Stage NSCLC

    • Type: Posters
    • Track: Immunotherapy (Phase II/III Trials)
    • Presentations: 2
    • Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
    • +

      P15.02 - Toripalimab and Platinum-Doublet Chemotherapy as Neoadjuvant Therapy for Potentially Resectable Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Yongchang Zhang

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P19 - Immunotherapy (Phase II/III Trials) - Previously Treated NSCLC

    • Type: Posters
    • Track: Immunotherapy (Phase II/III Trials)
    • Presentations: 2
    • Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
    • +

      P19.01 - RATIONALE-303 Phase 3 Tislelizumab vs Docetaxel in Previously Treated Advanced NSCLC: China Subgroup Analysis

      00:00 - 00:00  |  Presenter: Yun Fan

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P51 - Novel Therapeutics and Targeted Therapies - EGFR Resistance

    • Type: Posters
    • Track: Novel Therapeutics and Targeted Therapies
    • Presentations: 7
    • Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
    • +

      P51.03 - Oritinib (SH-1028), a Third-generation EGFR-TKI in Advanced NSCLC Patients with Positive EGFR T790M: Results of a Single-arm Phase Ib Trial

      00:00 - 00:00  |  Presenter: Caicun Zhou

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P60 - Predictive Tumor Based Assays/ Biomarkers/ Pathology - Other Biomarkers

    • Type: Posters
    • Track: Predictive Tumor Based Assays/ Biomarkers/ Pathology
    • Presentations: 14
    • Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
    • +

      P60.03 - Transcriptome and Genome Profiles of Metastatic Lung Cancers Highlighted Predictive Power of Infection-Related Model in Metastasis

      00:00 - 00:00  |  Presenter: Peixin Chen

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P66 - Small Cell Lung Cancer/ NET - Pre-Clinical

    • Type: Posters
    • Track: Small Cell Lung Cancer/ NET
    • Presentations: 9
    • Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
    • +

      P66.06 - GPNMB Associates With Inferior Prognosis in SCLC Patients Through Promoting Tumor Cell Metastasis

      00:00 - 00:00  |  Presenter: qian liu

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    PL02 - Plenary 2: Presidential Symposium (Japanese, Mandarin, Spanish Translation Available)

    • Type: Plenary
    • Track: N.A.
    • Presentations: 11
    • Moderators:David Harpole
    • Coordinates: 9/09/2021, 06:30 - 08:00, Program Auditorium
    • +

      PL02.05 - IMpower010: Characterization of Stage IB-IIIA NSCLC Patients by Type and Extent of Therapy Prior to Adjuvant Atezolizumab

      07:04 - 07:14  |  Presenter: Nasser Altorki

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    PL02A - Plenary 2: Presidential Symposium (Rebroadcast) (Japanese, Mandarin, Spanish Translation Available)

    • Type: Plenary
    • Track: N.A.
    • Presentations: 11
    • Moderators:David Harpole
    • Coordinates: 9/09/2021, 14:30 - 16:00, Program Auditorium
    • +

      PL02A.05 - IMpower010: Characterization of Stage IB-IIIA NSCLC Patients by Type and Extent of Therapy Prior to Adjuvant Atezolizumab

      15:04 - 15:14  |  Presenter: Nasser Altorki

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    WS06 - Joint IASLC - CAALC - CSCO Workshop: Looking Toward the Future: Recognizing and Curing Lung Cancer

    • Type: Workshop
    • Track: N.A.
    • Presentations: 9
    • Moderators:Caicun Zhou
    • Coordinates: 9/11/2021, 22:15 - 23:45, Program Auditorium
    • +

      WS06.01 - Introduction

      22:15 - 22:17  |  Presenter: ChunXue Bai

      • Abstract

      No abstract available for this presentation

    • +

      WS06.02 - RWS on PNapp MIOT Study on Pulmonary Nodule and Updates of 9th Edition of NSCLC TNM Staging Project in China

      22:17 - 22:29  |  Presenter: Dawei Yang

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      WS06.03 - Neoadjuvant/Adjuvant Target Therapy for Curing Driver Genes Positive Resectable NSCLC

      22:29 - 22:41  |  Presenter: Wen-zhao Zhong

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      WS06.04 - Neoadjuvant/Adjuvant Immunotherapy for Curing Non-driver Genes Resectable NSCLC

      22:41 - 22:53  |  Presenter: Heather Wakelee

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      WS06.05 - RATIONALE-307: Updated Biomarker Analysis of Phase 3 Study of Tislelizumab Plus Chemo vs Chemo Alone For 1L Advanced Sq-NSCLC

      22:53 - 23:03  |  Presenter: Jie Wang

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      WS06.06 - Drug Holiday Based on Minimal Residual Disease Status After Local Therapy Following EGFR-TKI Treatment for Patients With Advanced NSCLC

      23:03 - 23:13  |  Presenter: Song Dong

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      WS06.07 - Lorlatinib for Previously Treated ALK-Positive Advanced NSCLC: Primary Efficacy and Safety Data from a Phase 2 Study in China

      23:13 - 23:23  |  Presenter: Shun Lu

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      WS06.08 - Discussant

      23:23 - 23:31  |  Presenter: Mingfang Zhao

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      WS06.09 - Live Panel Discussion with Speakers and Chairs

      23:31 - 23:45  |  Presenter: Yi-Long Wu

      • Abstract

      No abstract available for this presentation

  • +

    MA13 - Building on the Past: What Will Be the Next Immunotherapy Combination?

    • Type: Mini Oral
    • Track: Immunotherapy (Phase II/III Trials)
    • Presentations: 9
    • Coordinates: 9/13/2021, 17:30 - 18:30, Program Auditorium
    • +

      MA13.01 - Camrelizumab Plus Apatinib in Treatment-Naive Patients With Advanced Non-Squamous NSCLC: A Multicenter, Open-Label, Single-Arm, Phase 2 Trial

      17:30 - 17:35  |  Presenter: Shengxiang (Harry) Ren

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      MA13.07 - GEMSTONE-302: A Phase 3 Study of Platinum-Based Chemotherapy with Placebo or Sugemalimab, a PD-L1 mAb, for metastatic NSCLC

      18:05 - 18:10  |  Presenter: Caicun Zhou

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      MA13.08 - CHOICE-01: A Phase 3 Study of Toripalimab Versus Placebo in Combination With First-Line Chemotherapy for Advanced NSCLC

      18:10 - 18:15  |  Presenter: Jie Wang

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.